Emergency: 9010550550
24/7 Service

Stay Ahead of GI Cancers

Integrated screening, targeted therapy, and survivorship for stomach, liver, and colon cancers

Book GI Cancer Screening
95%
Screening Completion
Eligible patients complete recommended tests within 2 weeks
88%
Stage 0-II Detection
Early-stage identification for colon and stomach cancers via surveillance
4 hrs
Tumour Board Consensus
Treatment plans finalised within four hours of board review

When to Consult

  • Family history of stomach, liver, or colon cancers
  • Unexplained weight loss, persistent anaemia, or fatigue
  • Blood in stools, black stools, or persistent abdominal pain
  • Chronic hepatitis B/C, cirrhosis, or heavy alcohol use
  • Long-standing ulcerative colitis or gastric ulcers
  • Previous polyps or lesions needing surveillance

Understanding GI Cancers in the Indian Context

Gastrointestinal cancers contribute nearly 20% of India’s cancer burden. Hepatitis, H. pylori, processed foods, and late screening amplify risks in Telangana. Ajuda Hospitals ensures early detection through endoscopy, ultrasound, and risk-based surveillance.

We streamline care from diagnosis to therapy, offering cashless approvals, accommodation support, and tele follow-ups for families travelling from Warangal, Karimnagar, or Nalgonda.

When to Consult Our GI Oncology Specialists

⚠️ Seek urgent care if you notice:

  • ✓ Vomiting blood or passing black stools
  • ✓ Sudden jaundice with weight loss
  • ✓ Persistent abdominal pain with fevers
  • ✓ Obstructive symptoms—vomiting, inability to eat, severe constipation

If you have risk factors or mild symptoms, schedule screening to catch disease before it advances.

Our Diagnostic Approach

Risk Assessment

Family history, hepatitis status, and lifestyle inform tailored screening plans.

High-Resolution Screening

Endoscopy, colonoscopy, ultrasound, and imaging detect lesions early.

Precision Pathology

Biopsies undergo molecular testing to guide targeted therapy.

Tumour Board Consensus

Specialist panel finalises treatment, ensuring all modalities align.

Treatment Pathways

Early lesions undergo endoscopic resection; intermediate cancers receive surgery plus chemo-radiation; advanced disease taps immunotherapy and liver-directed therapies. Survivorship clinics ensure nutrition, rehabilitation, and mental health support.

What to Expect: Your Care Journey

Week 0 screening → Week 1 diagnosis & staging → Week 2 therapy initiation → Month 3 response assessment → Yearly survivorship with structured surveillance.

Technology & Innovation

The GI Cancer Command Centre tracks every patient’s pathway, preventing delays. Tele tumour boards include referring doctors, enabling joint decisions.

Preventing Complications

Screening prevents emergency presentations with bleeding or obstruction. Vaccinating against hepatitis B and eliminating H. pylori lower cancer risk dramatically.

Why Ajuda for GI Cancer Care?

🧠 Tumour Board Expertise

Unified decisions from gastro, oncology, surgery, and radiology.

🔬 Precision Medicine

NGS panels and biomarker-driven regimens.

🤝 Survivorship Support

Nutrition, rehab, mental health, and return-to-work guidance.

Take the First Step

Call 9010550550 or book online to secure your GI cancer screening slot. Early detection saves lives—let Ajuda Hospitals guide you every step.

Diagnosis Approach

1

Risk Stratification & Genetic Review

Analyse family history, lifestyle, viral exposure, and genetic markers (Lynch, BRCA, etc.).

2

Endoscopic & Imaging Screening

High-definition endoscopy, colonoscopy, ultrasound, CT/MRI, and FibroScan for targeted evaluation.

3

Biopsy & Molecular Profiling

Histopathology, immunohistochemistry, and NGS panels for personalised therapy.

4

Multidisciplinary Tumour Board

Gastroenterology, surgical oncology, medical oncology, radiation, pathology, and nutrition craft a unified plan.

Treatment Options

Endoscopic Resection

EMR/ESD for early gastric or colon lesions, preserving organ function.

Curative in 80-90% of early-stage lesions
Day-care procedure

Targeted & Immunotherapy

HER2, VEGF, PD-L1 guided regimens, and checkpoint inhibitors for advanced disease.

Improves progression-free survival significantly
Cycle-based with monitoring

Liver-Directed Therapies

TACE, TARE, RFA, or microwave ablation for hepatocellular carcinoma.

Controls tumour in 60-70% intermediate stage cases
Planned sessions with imaging follow-up

Minimally Invasive GI Surgery

Laparoscopic or robotic gastrectomy, colectomy, or hepatectomy with ERAS protocols.

Shorter recovery with oncologically sound outcomes
3-7 day hospital stay

Chemo-Radiation Coordination

Neoadjuvant/adjuvant therapy scheduling, toxicity management, and supportive care.

Enhances resectability and survival
3-6 months based on protocol

Survivorship & Rehab Clinic

Nutrition, physiotherapy, psychological support, and surveillance scheduling.

Improves quality of life and early recurrence detection
Quarterly follow-ups

Expected Outcomes

Treatment Timeline

Week 1

Complete diagnostic workup and staging

Week 2

Tumour board plan shared; treatment initiated

Month 3

Response assessment via imaging/endoscopy

Year 1

Surveillance and survivorship roadmap in place

Success Metrics

  • Time-to-treatment ≤14 days from diagnosis
  • Pathological complete response tracked for neoadjuvant cases
  • 100% inclusion in survivorship registry